Showing results (101-110 of 122) with videos related to

Sort By:
Pageof 13
Clinical Neuropharmacology|December 1, 1993
Famotidine adjunctive pharmacotherapy for schizophrenia: preliminary dataS I Deutsch, R B Rosse, K A Kendrick, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 1, 1996
7-Nitroindazole and methylene blue, inhibitors of neuronal nitric oxide synthase and NO-stimulated guanylate cyclase, block MK-801-elicited behaviors in miceS I Deutsch, R B Rosse, S M Paul, et al.
Psychopharmacology|December 22, 1998
Both nicotine and mecamylamine block dizocilpine-induced explosive jumping behavior in mice: psychiatric implicationsY Tizabi, J Mastropaolo, C H Park, et al.
Clinical Neuropharmacology|October 5, 2001
Topiramate improves deficit symptoms in a patient with schizophrenia when added to a stable regimen of antipsychotic medicationA L Drapalski, R B Rosse, R R Peebles, et al.
Brain Research|June 30, 1987
Rapid increase in brain benzodiazepine receptor binding following defeat stress in miceL G Miller, M L Thompson, D J Greenblatt, et al.
Journal of Neurochemistry|November 1, 1987
Benzodiazepine receptor binding of triazolobenzodiazepines in vivo: increased receptor number with low-dose alprazolamL G Miller, D J Greenblatt, J G Barnhill, et al.
Clinical Neuropharmacology|February 1, 1994
L-tyrosine pharmacotherapy of schizophrenia: preliminary dataS I Deutsch, R B Rosse, B L Schwartz, et al.
Biochemical Pharmacology|February 1, 1985
The oxidation of p-phenetidine by horseradish peroxidase and prostaglandin synthase and the fate of glutathione during such oxidationsD Ross, R Larsson, B Andersson, et al.
Brain Research|May 15, 1989
Stress-induced behavioral depression in the rat is associated with a decrease in GABA receptor-mediated chloride ion flux and brain benzodiazepine receptor occupancyR C Drugan, A L Morrow, R Weizman, et al.
Clinical Neuropharmacology|October 1, 1989
Glycine adjuvant therapy to conventional neuroleptic treatment in schizophrenia: an open-label, pilot studyR B Rosse, S K Theut, M Banay-Schwartz, et al.
Pageof 13